Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Norepinephrine is a well-established, scientifically validated treatment for acute heart failure, particularly in the context of cardiogenic shock or severe hypotension (low blood pressure) due to heart weakness. Norepinephrine is a potent vasopressor and inotrope that acts primarily via stimulation of alpha-adrenergic receptors, leading to vasoconstriction and increased systemic vascular resistance, as well as some beta-1 adrenergic effects that can increase cardiac contractility and cardiac output. Its use is extensively documented in major clinical guidelines, such as those from the American Heart Association (AHA) and the European Society of Cardiology (ESC), which recommend norepinephrine as a first-line agent for managing hypotension in patients with acute heart failure or shock. Numerous randomized controlled trials and meta-analyses have demonstrated its efficacy and safety profile compared to other vasopressors, such as dopamine. Norepinephrine is considered superior to dopamine in terms of mortality and arrhythmic risks according to large studies (e.g., the SOAP II trial). Thus, its use for supporting circulation in settings of acute heart weakness is grounded in robust scientific evidence and is standard practice in critical care and cardiology.

More about Norepinephrine
More about Heart (weakness)

Other ingredients used for Heart (weakness)

Other health conditions supported by Norepinephrine

Products containing Norepinephrine